E4/DRSP Single and Multiple Dose PK and Early QT Study
NCT02874248
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Contraception
Interventions
DRUG:
15 mg E4/3 mg DRSP
DRUG:
30 mg E4/6 mg DRSP
DRUG:
60 mg E4/12 mg DRSP
DRUG:
Visually matching placebo
DRUG:
75 mg E4/15 mg DRSP
Sponsor
Estetra